Serial 87742969
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Oct 2025)
What this means for you
Registered since 01 Oct 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Oct 2029: the §8 & §9 renewal).
Record
- Serial number
- 87742969
- Registration number
- 5874961
- Mark type
- Design / logo
- Filed
- 04 Jan 2018
- Published for opposition
- 22 May 2018
- Registered
- 01 Oct 2019
- Next maintenance filing
- §8 & §9 renewal, due by 01 Oct 2029 (grace period to 01 Apr 2030)
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for the prevention and treatment of oncologic diseases
Owner
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
Prosecution history
- 02 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 May 2025 — TEAS SECTION 8 & 15 RECEIVED
- 01 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 27 Aug 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Aug 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Aug 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Aug 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Aug 2019 — ASSIGNED TO LIE
- 07 Aug 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 May 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 May 2019 — NON-FINAL ACTION E-MAILED
- 21 May 2019 — SU - NON-FINAL ACTION - WRITTEN